Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and

Carolin Klemm1, Christin Bruchhagen1, Andre van Krüchten1

  • 1Institute of Virology Muenster (IVM), Westfaelische Wilhelms-University Muenster, Von Esmarch-Str. 56, D-48149 Muenster, Germany.

Scientific Reports
|February 15, 2017
PubMed

Insights

Influenza virus and Staphylococcus aureus co-infections elevate interleukin-6 (IL-6) by activating specific MAPK pathways. Understanding these mechanisms is key to treating severe pneumonia caused by these super-infections.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pathology

Background:

  • Bacterial super-infections, particularly Staphylococcus aureus, are severe complications of influenza virus (IV) infections, leading to pneumonia.
  • Interleukin-6 (IL-6) is a key cytokine in inflammation, with elevated levels observed in severe IV and bacterial co-infections, but its regulation remains unclear.

Purpose of the Study:

  • To investigate the cellular signaling pathways governing IL-6 production during IV/S. aureus super-infection.
  • To elucidate the role of mitogen-activated protein kinases (MAPKs) in IL-6 regulation in this context.

Main Methods:

  • Studied IL-6 production in a model of IV/S. aureus super-infection.
  • Used lipoteichoic acid to mimic viable bacterial stimulation.
  • Analyzed MAPK pathway activation (p38, ERK1/2, JNK) and IL-6 expression.
  • Utilized MAPK inhibitors to assess pathway involvement.

Main Results:

  • Super-infection synergistically increased activation of MAPK p38 and phosphorylation of ERK1/2 and JNK.
  • IL-6 expression was significantly dependent on p38 and ERK1/2 activity.
  • MAPK JNK did not appear to play a significant role in IL-6 regulation.

Conclusions:

  • Identified specific MAPK pathways (p38 and ERK1/2) crucial for IL-6 regulation during bacterial super-infection post-influenza.
  • These findings offer molecular insights into the synergistic lethality of IV and S. aureus co-infections.
  • May inform therapeutic strategies targeting IL-6 in severe pneumonia.

Related Concept Videos